You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
Dow
Mallinckrodt
Baxter

Last Updated: November 30, 2023

Xiromed Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for XIROMED, and what generic and branded alternatives to XIROMED drugs are available?

XIROMED has forty-one approved drugs.



Summary for Xiromed
US Patents:0
Tradenames:39
Ingredients:28
NDAs:41

Drugs and US Patents for Xiromed

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiromed CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 215046-001 Aug 20, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Xiromed TRI-LO-ESTARYLLA ethinyl estradiol; norgestimate TABLET;ORAL-28 091232-001 Jun 29, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Xiromed ENILLORING ethinyl estradiol; etonogestrel RING;VAGINAL 211157-001 Jun 29, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Xiromed ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 216656-002 Apr 28, 2023 AO RX No No ⤷  Try a Trial ⤷  Try a Trial
Xiromed OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 212977-002 Dec 10, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Xiromed ALTAVERA ethinyl estradiol; levonorgestrel TABLET;ORAL-28 079102-001 Aug 3, 2010 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for XIROMED drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Harvard Business School
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.